Skip to main content
NCBI home page
Current Therapeutic Research, Clinical and Experimental logoLink to Current Therapeutic Research, Clinical and Experimental
. 2009 Feb;70(1):10–18. doi: 10.1016/j.curtheres.2009.02.005

Direct medical costs in patients with Alzheimer's disease in Taiwan: A population-based study

Agnes LF Chan 1,2, Thau-Ming Cham 1, Shun-Jin Lin 1,*
PMCID: PMC3969948  PMID: 24692828

Abstract

Background: Alzheimer's disease (AD) has the potential to become a major health concern and associated health care costs may become a significant economic burden on society.

Objective: The aim of this study was to estimate the direct medical costs attributable to AD in patients aged ≥60 years in Taiwan from 2000 through 2002 and to explore the correlation of these costs with patients' age and sex.

Methods: This study was based on the National Health Insurance Research Database of Taiwan's National Health Insurance (NHI) program. The NHI program insures >98% of the 23 million inhabitants of Taiwan. Detailed data were extracted from a random sample of 0.2% of inpatient and 5% of outpatient recipients with AD (International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis code 331.0) who were aged ≥60 years and who received inpatient or outpatient services with claims from January 1, 2000, to December 31, 2002. Duplicate charges for a specific patient and diagnoses of other types of dementia were excluded from this study.

Results: A total of 69,780 patients were found to have a diagnosis of AD. The direct medical costs for outpatients were estimated at US $1.2 million in 2000, US $1.9 million in 2001, and US $2.3 million in 2002; the costs for inpatient care were estimated at US $670,000 in 2000, US $2.4 million in 2001, and US $3.2 million in 2002. The total direct medical costs were estimated at US $1.86 million in 2000, US $4.24 million in 2001, and US $5.48 million in 2002. The increase of total direct medical costs was not significantly correlated with patients' age or sex.

Conclusions: From 2000 through 2002, the direct medical costs of AD increased annually in Taiwan among patients with AD aged ≥60 years. No significant correlation was found between increased total direct medical costs and sex or age. The cost estimate presented here has implications for future decision making about reallocating medical resources for treating AD in Taiwan.

Key words: Alzheimer's disease, direct medical costs, Taiwan

Full Text

The Full Text of this article is available as a PDF (661.3 KB).

References

  • 1.Zencir M, Kuzu N, Beşer NG. Cost of Alzheimer's disease in a developing country setting. Int J Geriatr Psychiatry. 2005;20:616–622. doi: 10.1002/gps.1332. [DOI] [PubMed] [Google Scholar]
  • 2.Zhang ZX, Zahner GE, Román GC. Dementia subtypes in China: Prevalence in Beijing, Xian, Shanghai, and Chengdu. Arch Neurol. 2005;62:447–453. doi: 10.1001/archneur.62.3.447. [DOI] [PubMed] [Google Scholar]
  • 3.Yamada T, Hattori H, Miura A. Prevalence of Alzheimer's disease, vascular dementia and dementia with Lewy bodies in a Japanese population. Psychiatry Clin Neurosci. 2001;55:21–25. doi: 10.1046/j.1440-1819.2001.00779.x. [DOI] [PubMed] [Google Scholar]
  • 4.Lin RT, Lai CL, Tai CT. Prevalence and subtypes of dementia in southern Taiwan: Impact of age, sex, education, and urbanization. J Neurol Sci. 1998;160:67–75. doi: 10.1016/s0022-510x(98)00225-1. [DOI] [PubMed] [Google Scholar]
  • 5.Liu HC, Lin KN, Teng EL. Prevalence and subtypes of dementia in Taiwan: A community survey of 5297 individuals. J Am Geriatr Soc. 1995;43:144–149. doi: 10.1111/j.1532-5415.1995.tb06379.x. [DOI] [PubMed] [Google Scholar]
  • 6.Liu HC, Chou P, Lin KN. Assessing cognitive abilities and dementia in a predominantly illiterate population of older individuals in Kinmen. Psychol Med. 1994;24:763–770. doi: 10.1017/s0033291700027914. [DOI] [PubMed] [Google Scholar]
  • 7.Amatniek JC, Frey LC, Hauser WA. Gender differences in diseases of nervous system. In: Kaplan PW, editor. Neurologic Disease in Women. Demos Medical Pub; New York, NY: 2006. pp. 433–442. [Google Scholar]
  • 8.Liu CK, Lin RT, Chen YF. Prevalence of dementia in an urban area in Taiwan. J Formos Med Assoc. 1996;95:762–768. [PubMed] [Google Scholar]
  • 9.Wimo A, Jonsson L, Winblad B. An estimate of the worldwide prevalence and direct costs of dementia in 2003. Dement Geriatr Cogn Disord. 2006;21:175–181. doi: 10.1159/000090733. [DOI] [PubMed] [Google Scholar]
  • 10.Wimo A, Winblad B, Jönsson L. An estimate of the total worldwide societal costs of dementia in 2005. Alzheimers Dement. 2003;7:81–91. doi: 10.1016/j.jalz.2007.02.001. [DOI] [PubMed] [Google Scholar]
  • 11.Dunkin JJ, Anderson-Hanley C. Dementia caregiver burden: A review of the literature and guidelines for assessment and intervention. Neurology. 1998;51(Suppl 1):S53–S60. doi: 10.1212/wnl.51.1_suppl_1.s53. discussion S65–S67. [DOI] [PubMed] [Google Scholar]
  • 12.Chiu L, Tang KY, Liu YH. Cost comparisons between family-based care and nursing home care for dementia. J Adv Nurs. 1999;29:1005–1012. doi: 10.1046/j.1365-2648.1999.00969.x. [DOI] [PubMed] [Google Scholar]
  • 13.Mueller E. The impact of demographic factors on economic development in Taiwan. Popul Dev Rev. 1977;3:1–22. [Google Scholar]
  • 14.Jönsson L, Eriksdotter Jönhagen M, Kilander L. Determinants of costs of care for patients with Alzheimer's disease. Int J Geriatr Psychiatry. 2006;21:449–459. doi: 10.1002/gps.1489. [DOI] [PubMed] [Google Scholar]
  • 15.Leon J, Neumann PJ. The cost of Alzheimer's disease in managed care: A cross-sectional study. Am J Manag Care. 1999;5:867–877. [PubMed] [Google Scholar]
  • 16.Chiu L, Tang KY, Liu YH. Willingness of families caring for victims of dementia to pay for nursing home care: Results of a pilot study in Taiwan. J Manag Med. 1998;12:321. doi: 10.1108/02689239810234571. 349–360. [DOI] [PubMed] [Google Scholar]
  • 17.ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Publications/ICD9-CM/2003/ World Health International Classification of Diseases, Ninth Revision, Clinical Modification, 2003 [CDC Web site] Accessed September 9, 2008.
  • 18.http://www.nhri.org.tw/nhird/date_04.htm National Health Insurance Research Database. Accessed September 9, 2008.
  • 19.Liu CK, Lai CL, Tai CT. Incidence and subtypes of dementia in southern Taiwan: Impact of socio-demographic factors. Neurology. 1998;50:1572–1579. doi: 10.1212/wnl.50.6.1572. [DOI] [PubMed] [Google Scholar]
  • 20.Andersen K, Launer LJ, Dewey ME, EURODEM Incidence Research Group Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. Neurology. 1999;53:1992–1997. doi: 10.1212/wnl.53.9.1992. [DOI] [PubMed] [Google Scholar]
  • 21.Meek PD, McKeithan K, Schumock GT. Economic considerations in Alzheimer's disease. Pharmacotherapy. 1998;18:68–73. discussion 79-82. [PubMed] [Google Scholar]
  • 22.Zhu CW, Scarmeas N, Torgan R. Clinical features associated with costs in early AD: Baseline data from the Predictors Study. Neurology. 2006;66:1021–1028. doi: 10.1212/01.wnl.0000204189.18698.c7. [DOI] [PubMed] [Google Scholar]
  • 23.Allegri RF, Butman J, Arizaga RL. Economic impact of dementia in developing countries: An evaluation of costs of Alzheimer-type dementia in Argentina. Int Psychogeriatr. 2007;19:705–718. doi: 10.1017/S1041610206003784. [DOI] [PubMed] [Google Scholar]
  • 24.Wang G, Cheng Q, Zhang S. Economic impact of dementia in developing countries: An evaluation of Alzheimer-type dementia in Shanghai, China. J Alzheimers Dis. 2008;15:109–115. doi: 10.3233/jad-2008-15109. [DOI] [PubMed] [Google Scholar]
  • 25.Iezzoni LI. Assessing quality using administrative data. Ann Intern Med. 1997;127:666–674. doi: 10.7326/0003-4819-127-8_part_2-199710151-00048. [DOI] [PubMed] [Google Scholar]
  • 26.Menzin J, Lang K, Friedman M. The economic cost of Alzheimer's disease and related dementias to the California Medicaid program (“Medi-Cal”) in 1995. Am J Geriatr Psychiatry. 1999;7:300–308. [PubMed] [Google Scholar]

Articles from Current Therapeutic Research, Clinical and Experimental are provided here courtesy of Elsevier

RESOURCES